[HTML][HTML] Afatinib for the Treatment of Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: An Updated Database of 1023 Cases Brief Report
Introduction Previously, we developed a database of 693 patients with NSCLC and
uncommon EGFR mutations treated with afatinib. Here, we provide an update of> 1000 …
uncommon EGFR mutations treated with afatinib. Here, we provide an update of> 1000 …
[HTML][HTML] Afatinib for the Treatment of Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: An Updated Database of 1023 Cases Brief Report
JCH Yang, M Schuler, S Popat, S Miura… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
Methods Patients were identified from a prospective database developed by Boehringer
Ingelheim and via literature review. Mutations were categorized as T790M-positive, exon 20 …
Ingelheim and via literature review. Mutations were categorized as T790M-positive, exon 20 …
Afatinib for the Treatment of Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: An Updated Database of 1023 Cases Brief Report
JCH Yang, M Schuler, S Popat… - Frontiers in …, 2022 - mdanderson.elsevierpure.com
Introduction: Previously, we developed a database of 693 patients with NSCLC and
uncommon EGFR mutations treated with afatinib. Here, we provide an update of> 1000 …
uncommon EGFR mutations treated with afatinib. Here, we provide an update of> 1000 …
Afatinib for the Treatment of Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: An Updated Database of 1023 Cases Brief Report
JCH Yang, M Schuler, S Popat, S Miura… - FRONTIERS IN …, 2022 - scholarworks.bwise.kr
IntroductionPreviously, we developed a database of 693 patients with NSCLC and
uncommon EGFR mutations treated with afatinib. Here, we provide an update of> 1000 …
uncommon EGFR mutations treated with afatinib. Here, we provide an update of> 1000 …
Afatinib for the Treatment of Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: An Updated Database of 1023 Cases Brief Report.
JC Yang, M Schuler, S Popat, S Miura, K Park… - Frontiers in …, 2022 - europepmc.org
Methods Patients were identified from a prospective database developed by Boehringer
Ingelheim and via literature review. Mutations were categorized as T790M-positive, exon 20 …
Ingelheim and via literature review. Mutations were categorized as T790M-positive, exon 20 …
Afatinib for the Treatment of Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: An Updated Database of 1023 Cases Brief Report
JCH Yang, M Schuler, S Popat, S Miura… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction Previously, we developed a database of 693 patients with NSCLC and
uncommon EGFR mutations treated with afatinib. Here, we provide an update of> 1000 …
uncommon EGFR mutations treated with afatinib. Here, we provide an update of> 1000 …
Afatinib for the Treatment of Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: An Updated Database of 1023 Cases Brief Report.
JCH Yang, M Schuler, S Popat, S Miura… - Frontiers in …, 2022 - repository.icr.ac.uk
Introduction: Previously, we developed a database of 693 patients with NSCLC and
uncommon EGFR mutations treated with afatinib. Here, we provide an update of> 1000 …
uncommon EGFR mutations treated with afatinib. Here, we provide an update of> 1000 …
[PDF][PDF] Afatinib for the Treatment of Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: An Updated Database of 1023 Cases Brief Report. Front
JCH Yang, M Schuler, S Popat, S Miura, K Park… - Oncol, 2022 - repository.icr.ac.uk
Methods: Patients were identified from a prospective database developed by Boehringer
Ingelheim and via literature review. Mutations were categorized as T790M-positive, exon 20 …
Ingelheim and via literature review. Mutations were categorized as T790M-positive, exon 20 …